PDS Biotechnology (PDSB) Misses Q2 EPS by 2c
PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.